Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Brienza

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
American Journal of Respiratory and Critical Care Medicine|April 17, 2010
T Cells localize with proliferating smooth muscle alpha-actin+ cell compartments in asthmaDavid Ramos-Barbón, Rebeca Fraga-Iriso, Nadia S Brienza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 1999
Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgeryS Giacchetti, M Itzhaki, G Gruia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): results from the European compassionate-use programS Brienza, M A Bensmaïne, P Soulié, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidinesD Machover, E Diaz-Rubio, A de Gramont, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2009
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanesS Pecorelli, I Ray-Coquard, O Tredan, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
American Journal of Respiratory and Critical Care Medicine|April 17, 2010
T Cells localize with proliferating smooth muscle alpha-actin+ cell compartments in asthmaDavid Ramos-Barbón, Rebeca Fraga-Iriso, Nadia S Brienza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 1999
Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgeryS Giacchetti, M Itzhaki, G Gruia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): results from the European compassionate-use programS Brienza, M A Bensmaïne, P Soulié, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidinesD Machover, E Diaz-Rubio, A de Gramont, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2009
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanesS Pecorelli, I Ray-Coquard, O Tredan, et al.
Pageof 6